C yclin A2 is a core cell cycle regulator that activates Cdk1 and Cdk2. Cyclin A2 levels increase upon S phase entry and remain high until its proteasome-dependent destruction in prometaphase (1) . Cyclin A2-Cdk complexes that assemble at the onset of S phase drive chromosome duplication through phosphorylation of key DNA replication factors. Subsequently, cyclin A2-Cdk activity initiates mitosis by phosphorylating and inactivating the protein kinase Wee1, resulting in activation and nuclear localization of cyclin B1-Cdk1. During early mitosis, cyclin A2 is implicated in mitotic spindle anchoring (2) and correction of aberrant kinetochore-microtubule attachments (3) . Furthermore, in a Cdk-independent manner, cyclin A2 regulates RhoA and RhoC, two guanosine triphosphatases implicated in cell morphogenesis, adhesion, and migration (4) .
In mice, cyclin A2 is essential for early embryogenesis, limiting investigations of its biological functions (5) . Studies of conditional knockout mice revealed that cyclin A2 is essential for cell cycle progression of certain cell types, including pluripotent and hematopoietic stem cells and select neuronal progenitors, yet is dispensable in fibroblasts because of redundancy with cyclin E in this cell type (6) . To uncover novel biological processes that critically depend on a full complement of cyclin A2, we used a combination of knockout (Ccna2 -) and hypomorphic (Ccna2 H ) alleles to markedly down-regulate cyclin A2 expression in mice without overtly affecting embryogenesis or postnatal development. Ccna2 H was created by targeted insertion of a neomycin resistance cassette into Ccna2 intron 2; Ccna2 -was created by gene trap mutagenesis ( fig. S1 , A to D). Ccna2
-/H mice showed markedly reduced levels of cyclin A2 protein in tissues with a high mitotic index, including small intestine, bone marrow, and spleen (Fig. 1A) . In contrast, cyclin A2 levels appeared normal in tissues with few cycling cells, such as brain, liver, and lung. However, actively cycling cultured lung epithelial cells from Ccna2 -/H mice had lower amounts of cyclin A2 relative to the wild type (Fig. 1A) . Analysis of mouse embryonic fibroblasts (MEFs) confirmed this, with Ccna2
MEFs expressing only~25% of normal cyclin A2 levels ( Fig. 1A and fig. S1E ). In Ccna2 +/+ MEFs, cyclin A2 expression typically started to increase during G 1 and peaked from G 2 until prophase ( fig.  S2 ). Cyclin A2 levels remained low in Ccna2 -/H MEFs throughout the cell cycle, resulting in markedly reduced Cdk activity during S and G 2 phase ( fig. S3 ). Despite these abnormalities,
Ccna2
-/H MEFs showed a normal cell cycle profile ( fig. S4 ). Both cyclin A2 deficiency and overabundance have been observed in human tumors and predict poor clinical outcome (7), but whether and how cyclin A2 deregulation drives malignant growth is unknown. To determine whether reduced cyclin A2 expression contributes to tumorigenesis, we treated Ccna2 +/+ and Ccna2 -/H mice with 7,12-dimethylbenz(a)anthracene (DMBA), a carcinogen that predisposes mice to lung adenomas and skin papillomas (8) . Ccna2 -/H mice showed a marked increase in tumor incidence and multiplicity in both lung and skin (Fig. 1B) Fig. 2A) . The latter are the result of merotelic attachment, a microtubule-kinetochore malattachment caused by spindle defects, including defects in attachment error correction, microtubule dynamics, mitotic timing, centrosome disjunction, and centrosome movement (9) . We systematically screened Ccna2
MEFs for lagging chromosomes, and by measuring the separation between centrosomes in G 2 and prophase, we found that the movement of sister centrosomes to opposite poles was impaired ( Fig. 2B and fig. S5 , B to F). Cells with delayed centrosome separation form asymmetrical spindles and lagging chromosomes at increased rates (10 3A and fig. S6 , C to G). Phosphorylation of checkpoint kinase 1 (Chk1) at Ser 345 (S345), a marker of replication stress (14) , was elevated in Ccna2
-/H MEFs (Fig. 3B) S7, M and N) .
The MRN complex, composed of Mre11, Rad50, and Nbs1, plays a central role in both replication fork restart and DSB repair (15) . Western blot analysis revealed that levels of Mre11 and Rad50 protein, but not Nbs1 protein, were consistently reduced in both irradiated and nonirradiated Ccna2 -/H MEFs (Fig. 3C) . Levels of Mre11 and Rad50 were also low in Ccna2 -/H tumors, although Cdk2 activity appeared normal ( fig. S8 ). Analysis of cell cycle-dependent expression showed that both Mre11 and Rad50 levels peaked in Ccna2 +/+ MEFs during S and G 2 phase, similar to cyclin A2 expression (figs. S9 and S10). Expression of Mre11 and Rad50 in S and G 2 phases was substantially lower in Ccna2
-/H MEFs. Ectopic expression of cyclin A2 restored both Mre11 and Rad50 protein levels (Fig. 3D ). Mre11 and Rad50 mRNA levels and ratios of nuclear to cytoplasmic distribution in Ccna2 -/H MEFs were similar to those of Ccna2 +/+ MEFs ( fig. S11 , A to C), indicating that reduced expression of Mre11 and Rad50 was not due to altered transcription or defective nuclear export. Furthermore, proteasome degradation was not responsible, as treatment of Ccna2
-/H MEFs with the proteasome inhibitor MG132 did not alter Mre11 and Rad50 levels ( fig. S11D ). However, Mre11 and Rad50 mRNA abundance in polysomes was reduced in Ccna2
-/H MEFs, suggesting reduced translation (Fig. 3E and fig.  S12 , A to C). To determine whether this was a direct effect, we immunoprecipitated cyclin A2 and analyzed it for the presence of Mre11, Rad50 transcripts, and several control transcripts by quantitative reverse transcription polymerase chain reaction (RT-qPCR). Intriguingly, cyclin A2 selectively precipitated Mre11 transcripts in Ccna2 +/+ MEFs (Fig. 3F) . Similar results were obtained using human primary fibroblasts and HeLa cells ( fig. S12D ). Cyclin A2 knockdown in these cells resulted in reduced MRE11 and RAD50 protein levels, consistent with results in Ccna2 -/H MEFs ( fig. S12E ). Cyclin A1 had no Mre11 RNA binding ability ( fig. S12, F and G) . Two observations suggested that cyclin A2 regulation of Mre11 and Rad50 was Cdk-independent: Neither Cdk2 nor Cdk1 immunoprecipitation enriched Mre11 transcripts comparably to cyclin A2 immunoprecipitation ( fig. S12H) , and inhibition of Cdk2 activity in wild-type MEFs by roscovitine had no impact on Mre11 levels ( fig. S12I ). Mre11 knockdown resulted in low Rad50 protein levels, but Rad50 depletion did not affect Mre11, indicating that Rad50 abundance is Mre11-dependent ( fig. S13, A 
and B). Ectopic expression of Mre11 in Ccna2
-/H MEFs normalized both Mre11 and Rad50 protein levels but had no impact on cyclin A2 levels (Fig. 3G) . Coincidentally, polysome association of Rad50 mRNA was restored ( fig. S13C) complex implicated in end resection, was subnormal in Ccna2 -/H MEFs through a Cdk2-dependent, Mre11-independent mechanism and therefore is unlikely to contribute to the chromosomal phenotype of Ccna2 -/H cells ( fig. S14 ).
RNA sequencing analysis of cyclin A2, E2, and B1 immunoprecipitates demonstrated that cyclin A2 exclusively binds Mre11 transcripts and that cyclins E2 and B1 have no RNA binding ability (tables S1 to S3). Mre11 RNA sequence reads exclusively mapped to the 3′ untranslated region (3′UTR), indicating that this region contains the cyclin A2 binding site ( fig. S15A ). When introduced downstream of a luciferase reporter, the Mre11 3′UTR enhanced luciferase activity in Ccna2 +/+ MEFs but not in Ccna2 -/H MEFs (Fig. 3H ).
Ectopic expression of cyclin A2 in Ccna2 -/H MEFs corrected this deficiency ( fig. S15B ). Expression of hemagglutinin (HA)-tagged cyclin A2 deletion mutants in MEFs revealed that residues 302 to 432 are necessary and sufficient for Mre11 transcript binding (Fig. 4A) . This fragment, which lacks Cdk-binding ability, restored Mre11 and Rad50 expression and prevented DSB formation in Ccna2 -/H MEFs ( Fig.   4B and fig. S16A ) but did not correct Cdkdependent phenotypes such as Eg5 loading, centrosome movement, spindle geometry, and chromosome lagging ( fig. S16 , B to F). Conversely, expression of amino acids 1 to 301, a fragment that binds to Cdk, corrected the latter defects but failed to restore Mre11 and Rad50 expression and DSB repair (fig. S16, G to K). Using deletion mutagenesis, we identified two subregions within the Mre11 3′UTR, a 150-nucleotide (nt) segment at the 5′ end and a 34-nt segment at the 3′ end, as potential cyclin A2 binding sites (Fig. 4C) . Recombinant glutathione S-transferase (GST)-cyclin A2 directly bound a radiolabeled RNA probe spanning the last 32 nt of the Mre11 3′UTR in an electrophoretic mobility shift assay, but not a scrambled 32-nt oligomer (32-mer) (Fig. 4D and fig. S17 , A and B). Neither GST-cyclin A2 nor GST-cyclin A2 302-432(4M) , which carries mutations in four putative ribonucleic acid contact sites required for restoration of Mre11 and Rad50 expression in Ccna2 MEFs by ectopic expression of cyclin A2 ( fig. S17 , B to E), was able to bind the Mre11 RNA probe (Fig. 4D) .
Translation initiation factor eIF4A2, a previously documented putative cyclin A2 interactor (16) , supershifted GST-cyclin A2 -bound Mre11 RNA complexes but did not bind the probe in the absence of cyclin A2 (Fig. 4E) . eIF4A2, but not Cdk1 or Cdk2, coimmunoprecipitated cyclin A2 under physiological conditions, indicating that cyclin A2 bound to Mre11 mRNA is free of Cdk binding partners (Fig. 4F) . Cyclin A2 interacted with eIF4A2 and Mre11 RNA through a common domain (fig. S17F) fig. S20 ). Our work exposed two novel cyclin A2 functions. First, we identified a role for the cyclin A2 N terminus in the formation of bipolar mitotic spindles by regulating Eg5 loading onto centrosomes through phosphorylation of T926. Second, the C terminus of cyclin A2, which has low sequence conservation among cyclin family members, directly binds to a conserved region in the 3′UTR of Mre11 transcripts to promote their translation, presumably through an interaction with eIF4A2. In doing so, cyclin A2 coordinates its well-established Cdk-dependent functions in the initiation and progression of DNA synthesis (16) while simultaneously reinforcing stabilization of the key machinery responsible for repairing DNA lesions caused by replication errors. Cyclins have hitherto not been implicated in RNA binding. The observation that cyclin A2 seemingly interacts with just a single transcript, Mre11 mRNA, was unexpected and appears to be a unique feature among RNA binding proteins. MEF lines per genotype). *P < 0.05, **P < 0.01, ***P < 0.001 (unpaired t test).
